Immunochemotherapeutic increase of peripheral absolute monocyte count predicts interstitial pneumonia in lymphoma patients-Reference-Cited by-同舟云学术

Immunochemotherapeutic increase of peripheral absolute monocyte count predicts interstitial pneumonia in lymphoma patients

Published:2018-09-19 Issue:5 Volume:36 Page:779-785
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Lang Mingxiao¹^ORCID,Yu Jingwei¹,Wang Xianhuo¹,Song Zheng¹,Li Lanfang¹,Qiu Lihua¹,Zhang Huilai¹

Affiliation:

1. National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Sino‐US Center for Lymphoma and Leukemia, Department of LymphomaTianjin Medical University Cancer Institute and Hospital Tianjin China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2556

Reference33 articles.

1. Non-Hodgkin lymphoma

2. Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma

3. Fatal Interstitial Pneumonitis Related to Rituximab-Containing Regimen

4. Incidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximab

5. Severe Pulmonary Adverse Effects in Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Regimen Plus Rituximab

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-Analysis of Risk Factors and Incidence of Interstitial Pneumonia With CHOP-Like Regimens for Non-Hodgkin Lymphoma;Frontiers in Oncology;2022-06-01

2. Not all bad: Drug-induced interstitial pneumonia in DLBCL patients is potentially fatal but could be linked to better survival;Leukemia Research;2021-12

3. Factors Associated With Efficacy and Nivolumab-Related Interstitial Pneumonia in Non-Small Cell Lung Cancer: A Retrospective Survey;Cancer Control;2020-01-01